181 related articles for article (PubMed ID: 31849155)
21. [Clinical significance of early percutaneous coronary intervention in patients with Braunwald III-B type unstable angina pectoris].
Nozaki K; Nakao K; Horiuchi K; Kasanuki H; Honda T
J Cardiol; 2003 Jun; 41(6):263-70. PubMed ID: 12845880
[TBL] [Abstract][Full Text] [Related]
22. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
[TBL] [Abstract][Full Text] [Related]
23. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
24. Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xu X; Liu X; Yu L; Ma J; Yu S; Ni M
Exp Ther Med; 2020 Jan; 19(1):137-146. PubMed ID: 31853283
[TBL] [Abstract][Full Text] [Related]
25. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
Patel DJ; Purcell HJ; Fox KM
Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
[TBL] [Abstract][Full Text] [Related]
27. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Ji Z; Zhang R; Lu W; Ma G; Qu Y
Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
[TBL] [Abstract][Full Text] [Related]
28. Clinical potential of oral nicorandil to improve myocardial fatty acid metabolism after percutaneous coronary intervention in hemodialysis patients.
Nishimura M; Okamoto Y; Tokoro T; Sato N; Nishida M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
Nephron Clin Pract; 2014; 126(1):24-32. PubMed ID: 24434794
[TBL] [Abstract][Full Text] [Related]
29. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
Yang J; Zhang J; Cui W; Liu F; Xie R; Yang X; Gu G; Zheng H; Lu J; Yang X; Zhang G; Wang Q; Geng X
Anatol J Cardiol; 2015 Feb; 15(2):125-31. PubMed ID: 25252296
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
[TBL] [Abstract][Full Text] [Related]
31. [A randomized double-blinded controlled trial of Xuefu Zhuyu Capsule on short-term quality of life in unstable anginal patients with blood-stasis syndrome after percutaneous coronary intervention].
Chu FY; Wang J; Sun XW; Xing YW; Yao KW; Wang SH; Li ZZ
Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):729-35. PubMed ID: 19671410
[TBL] [Abstract][Full Text] [Related]
32. The Efficacy and Safety of Nicorandil for Periprocedural Myocardial Injury in Patients Undergoing PCI: A Meta-Analysis.
Lu Y; Hu W; Song Q; Wang Q
J Interv Cardiol; 2020; 2020():3293587. PubMed ID: 33214774
[TBL] [Abstract][Full Text] [Related]
33. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
[TBL] [Abstract][Full Text] [Related]
34. Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease.
Zong Y; Li J; Xu X; Xu X
J Int Med Res; 2021 Dec; 49(12):3000605211058873. PubMed ID: 34871513
[TBL] [Abstract][Full Text] [Related]
35. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris.
Kishida H; Murao S
Clin Pharmacol Ther; 1987 Aug; 42(2):166-74. PubMed ID: 2955996
[TBL] [Abstract][Full Text] [Related]
36. Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon.
Kawai Y; Hisamatsu K; Matsubara H; Dan K; Akagi S; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T
Eur Heart J; 2009 Apr; 30(7):765-72. PubMed ID: 19276198
[TBL] [Abstract][Full Text] [Related]
37. A case of vasospastic angina in which the ergonovine provocation test with intracoronary isosorbide dinitrate and nicorandil was effective in the diagnosis of microvascular spasm.
Kiyooka T; Kobayashi Y; Ikari Y
Cardiovasc Interv Ther; 2014 Oct; 29(4):344-9. PubMed ID: 24407773
[TBL] [Abstract][Full Text] [Related]
38. Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial.
Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Nakamura K; Ito H;
Circ J; 2018 Jun; 82(7):1788-1796. PubMed ID: 29669963
[TBL] [Abstract][Full Text] [Related]
39. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.
Völz S; Dworeck C; Redfors B; Pétursson P; Angerås O; Gan LM; Götberg M; Sarno G; Venetsanos D; Grimfärd P; Hofmann R; Jensen J; Björklund F; Danielewicz M; Linder R; Råmunddal T; Fröbert O; Witt N; James S; Erlinge D; Omerovic E
J Am Coll Cardiol; 2020 Jun; 75(22):2785-2799. PubMed ID: 32498806
[TBL] [Abstract][Full Text] [Related]
40. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
